SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Calypte Biomedical Corporation (CALY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sherman Chen who wrote (198)11/8/1997 1:40:00 PM
From: JanyBlueEyes  Read Replies (1) of 381
 
ACTUAL ARTICLES FROM NATURE MAGAZINE

Some pretty technical stuff here.

Here is the link explaining what the articles mean:
Click here > siliconinvestor.com

Increased sensitivity of HIV-1 antibody detection
medicine.nature.com

Howard B. Urnovitz, Jerrilyn C. Sturge & Toby D. Gottfried
Calypte Biomedical, 1440 Fourth Street, Berkeley, California 94710, USA

Clinical trial results from 11,344 paired urine and serum samples revealed 1,181 HIV-1 positive individuals confirmed by western blot (WB).

There were 25 discrepant samples:

-10 were urine enzyme immunassay (EIA) and WB positive, serum non-reactive and serum WB negative or indeterminate, and

-15 were serum EIA and WB positive, urine EIA non-reactive or urine WB negative or indeterminate.

Serum samples, HIV-1 antibody WB confirmed, revealed a 99.15% sensitivity (1,171 out of 1,181);

urine samples, HIV-1 antibody WB confirmed, showed a 98.73% sensitivity (1,166 out of 1,181).

This study demonstrated that neither serum nor urine results alone are as sensitive for HIV-1 antibody detection as combined results of both samples.

--------------------------------

HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
medicine.nature.com

HIV-specific mucosal and cellular immunity was analyzed in heterosexual couples discordant for HIV status in serum and in HIV-unexposed controls.

HIV-specific IgA but not IgG was present in urine and vaginal wash samples from HIV-exposed seronegative individuals (ESN), whereas both IgA and IgG were observed in their HIV-seropositive partners; antibodies were not detected in low-risk controls.

Envelope protein (Env) peptide-stimulated interleukin-2 (IL-2) production by peripheral blood mononuclear cells (PBMCs) was detected in 9 out of 16 ESNs, 5 out of 16 HIV-infected patients and 1 out of 50 controls. Env peptide-stimulated PBMCs of ESNs produced more IL-2 and less IL-10 compared with those of HIV-infected individuals; no differences were observed in chemokine production or in CCR5 expression.

These data demonstrate that a compartmentalized immune response to pathogens is possible in humans and raise the possibility of protective roles for cell-mediated immunity and mucosal IgA in HIV-seronegative individuals exposed to HIV.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext